Hypokalemia
Recent clinical, regulatory, research and industry developments relating to this disease.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes1
- Dietary Supplements1
Leading journals2
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology1
- Kidney international1
Leading researchers8
- Bauml JM1
- Blanchard A1
- Bockenhauer D1
- Bolignano D1
- Calò LA1
- Cho BC1
- Cosyns E1
- Curtin JC1
Affiliations (unnormalised)6
- Asan Medical Center1
- Center for Molecular Medicine1
- Centre d'Investigation Clinique1
- Centre for Nephrology1
- Chungbuk National University Hospital1
- City of Hope Comprehensive Cancer Center1
Associated genes
Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.
Reference
Authoritative identity, definition & identifiers.
Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed)
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.